Cargando…
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522736/ https://www.ncbi.nlm.nih.gov/pubmed/37581752 http://dx.doi.org/10.1007/s12185-023-03646-3 |
_version_ | 1785110417663590400 |
---|---|
author | Izutsu, Koji Yamamoto, Kazuhito Kato, Koji Ishikawa, Takayuki Fukuhara, Noriko Terui, Yasuhito Choi, Ilseung Okubo, Sumiko Ogawa, Natsumi Sakai, Mizu Nishimura, Yasuko Chyla, Brenda Sun, Yan Maruyama, Dai |
author_facet | Izutsu, Koji Yamamoto, Kazuhito Kato, Koji Ishikawa, Takayuki Fukuhara, Noriko Terui, Yasuhito Choi, Ilseung Okubo, Sumiko Ogawa, Natsumi Sakai, Mizu Nishimura, Yasuko Chyla, Brenda Sun, Yan Maruyama, Dai |
author_sort | Izutsu, Koji |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10522736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-105227362023-09-28 Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax Izutsu, Koji Yamamoto, Kazuhito Kato, Koji Ishikawa, Takayuki Fukuhara, Noriko Terui, Yasuhito Choi, Ilseung Okubo, Sumiko Ogawa, Natsumi Sakai, Mizu Nishimura, Yasuko Chyla, Brenda Sun, Yan Maruyama, Dai Int J Hematol Letter to the Editor Springer Nature Singapore 2023-08-15 2023 /pmc/articles/PMC10522736/ /pubmed/37581752 http://dx.doi.org/10.1007/s12185-023-03646-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Izutsu, Koji Yamamoto, Kazuhito Kato, Koji Ishikawa, Takayuki Fukuhara, Noriko Terui, Yasuhito Choi, Ilseung Okubo, Sumiko Ogawa, Natsumi Sakai, Mizu Nishimura, Yasuko Chyla, Brenda Sun, Yan Maruyama, Dai Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
title | Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
title_full | Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
title_fullStr | Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
title_full_unstemmed | Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
title_short | Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
title_sort | measurable residual disease in japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522736/ https://www.ncbi.nlm.nih.gov/pubmed/37581752 http://dx.doi.org/10.1007/s12185-023-03646-3 |
work_keys_str_mv | AT izutsukoji measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT yamamotokazuhito measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT katokoji measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT ishikawatakayuki measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT fukuharanoriko measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT teruiyasuhito measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT choiilseung measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT okubosumiko measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT ogawanatsumi measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT sakaimizu measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT nishimurayasuko measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT chylabrenda measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT sunyan measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax AT maruyamadai measurableresidualdiseaseinjapanesepatientswithrelapsedorrefractorychroniclymphocyticleukemiatreatedwithvenetoclax |